Analysis of the time course of actions of glucose-lowering agents in outcome studies reveals that, unlike the rapid cardioprotective effects detected with use of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors (11), the cardiovascular benefits of GLP-1RAs take longer to emerge (10, 12), suggesting distinct mechanisms for these 2 classes of agents
| 04.21.26 | 12 min read
In addition to health journaling, you should also record your weight and any relevant body measurements, and monitor your glucose levels throughout the day (in patients with diabetes) so your doctor can understand the medical impact GLP-1s have had on you
Losing weight may be a big decision to make, but as long as you have strong commitment, willpower, and discipline, you can be successful at it
Shop now at Bestural.com
At the same time, GLP-1 receptor agonists offer documented cardiovascular and renal benefits